Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 2
- Registration Number
- NCT00437606
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 200
- Registration Number
- NCT00437619
A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 45
- Registration Number
- NCT00436241
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 551
- Registration Number
- NCT00435825
A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 39
- Registration Number
- NCT00436163
A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.
Phase 4
Terminated
- Conditions
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00436124
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 16
- Registration Number
- NCT00435929
VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-02-05
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 325
- Registration Number
- NCT00431353
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 545
- Registration Number
- NCT00430352
- Locations
- 🇦🇺
Mount Medical Center, Perth, Western Australia, Australia
🇧🇷Clinica Oncologica De Piracicaba Sc, Piracicaba, SP, Brazil
🇩🇪Dres.Andreas Karcher und Stefan Fuxius, Heidelberg, Germany
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-01-23
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 52
- Registration Number
- NCT00425438
© Copyright 2024. All Rights Reserved by MedPath